Publication | Closed Access

Impact of adjuvant anti-estrogen therapies (tamoxifen and aromatase inhibitors) on perioperative outcomes of breast reconstruction

Surgical OncologyBreast OncologyMedicineGynecologyAromataseBreast CancerSurgeryAdjuvant Anti-estrogen TherapiesPerioperative OutcomesBreast SurgeryBreast ReconstructionOncologyEndocrine-related CancerWomen's Health